Global Cancer Biomarkers Market to US$58 Billion by 2032 Driven by Precision Oncology and Liquid Biopsy Advancements
Industry Experts, Inc. has released its latest market research report, " Global Cancer Biomarkers Market - Types, Applications and Technologies ," estimating that the global cancer biomarkers market will expand from US$27.6 billion in 2025 to US$58 billion by 2032, registering a strong CAGR of 11.2% during 2025-2032. Growth is being driven by the rising global cancer burden, increasing emphasis on early and accurate diagnosis, and rapid adoption of biomarker-guided precision oncology. Cancer biomarkers are measurable biological indicators that support cancer detection, prognosis, treatment selection, and therapy monitoring across a wide range of malignancies. Increasing reliance on molecular profiling to guide targeted therapies, combined with growing adoption of liquid biopsy techniques based on circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and exosomes, has significantly expanded the clinical role of biomarkers. Advances in next-generation seque...